Pediatric Anxiety — Underrecognized and Undertreated
- 25 December 2008
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 359 (26), 2835-2836
- https://doi.org/10.1056/nejme0809401
Abstract
Generalized anxiety disorder, separation anxiety disorder, and social phobia are relatively prevalent disorders that affect 6 to 20% of children and adolescents.1 However, these disorders frequently go unrecognized by medical professionals. This is a critical problem, since a younger age of onset and severity of illness result in poor outcomes in adolescents and adults. Furthermore, the failure to identify these disorders early in life leads to increased rates of anxiety disorders, depression, and substance abuse later in life, as well as to educational underachievement.2 In this issue of the Journal, the report by Walkup et al. on the Child–Adolescent Anxiety . . .Keywords
This publication has 4 references indexed in Scilit:
- Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood AnxietyNew England Journal of Medicine, 2008
- Fluoxetine for the Treatment of Childhood Anxiety DisordersJournal of the American Academy of Child & Adolescent Psychiatry, 2003
- Life Course Outcomes of Young People With Anxiety Disorders in AdolescenceJournal of the American Academy of Child & Adolescent Psychiatry, 2001
- Early intervention and prevention of anxiety disorders in children: Results at 2-year follow-up.Journal of Consulting and Clinical Psychology, 1999